Niacin ameliorates ulcerative colitis via prostaglandin D2‐mediated D prostanoid receptor 1 activation

Niacin, as an antidyslipidemic drug, elicits a strong flushing response by release of prostaglandin (PG) D2. However, whether niacin is beneficial for inflammatory bowel disease (IBD) remains unclear. Here, we observed niacin administration‐enhanced PGD2 production in colon tissues in dextran sulfate sodium (DSS)‐challenged mice, and protected mice against DSS or 2,4,6‐trinitrobenzene sulfonic acid (TNBS)‐induced colitis in D prostanoid receptor 1 (DP1)‐dependent manner. Specific ablation of DP1 receptor in vascular endothelial cells, colonic epithelium, and myeloid cells augmented DSS/TNBS‐induced colitis in mice through increasing vascular permeability, promoting apoptosis of epithelial cells, and stimulating pro‐inflammatory cytokine secretion of macrophages, respectively. Niacin treatment improved vascular permeability, reduced apoptotic epithelial cells, promoted epithelial cell update, and suppressed pro‐inflammatory gene expression of macrophages. Moreover, treatment with niacin‐containing retention enema effectively promoted UC clinical remission and mucosal healing in patients with moderately active disease. Therefore, niacin displayed multiple beneficial effects on DSS/TNBS‐induced colitis in mice by activation of PGD2/DP1 axis. The potential efficacy of niacin in management of IBD warrants further investigation.

• Publication year

  2017

• Venue

  EMBO Molecular Medicine

• Publication date

  2017-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.15252/emmm.201606987PMID 28341703PMCID 5412792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Niacin ameliorates ulcerative colitis via prostaglandin D2‐mediated D prostanoid receptor 1 activation

  2017cited by this paper
• Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1

  2017cited by this paper
• Genetics and Pathogenesis of Inflammatory Bowel Disease.

  2016cited by this paper
• PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation

  2016cited by this paper
• Contribution of alveolar type II cell‐derived cyclooxygenase‐2 to basal airway function, lung inflammation, and lung fibrosis

  2016cited by this paper
• EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling.

  2015cited by this paper
• Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis.

  2015cited by this paper
• Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

  2015cited by this paper
• Eicosanoid storm in infection and inflammation

  2015cited by this paper
• Vitamin D Inhibits COX-2 Expression and Inflammatory Response by Targeting Thioesterase Superfamily Member 4*

  2014influential reference
• Opposing Roles of Prostaglandin D2 Receptors in Ulcerative Colitis

  2014cited by this paper
• Niacin attenuates the production of pro-inflammatory cytokines in LPS-induced mouse alveolar macrophages by HCA2 dependent mechanisms.

  2014cited by this paper
• Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.

  2014cited by this paper
• Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages

  2014cited by this paper
• The role of HCA2 (GPR109A) in regulating macrophage function

  2013cited by this paper
• Novel pharmacologic approaches to the prevention and treatment of ulcerative colitis.

  2013influential reference
• Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host.

  2013cited by this paper
• Cyclooxygenase-2–Derived Prostaglandin E2 Promotes Injury-Induced Vascular Neointimal Hyperplasia Through the E-prostanoid 3 Receptor

  2013cited by this paper
• Niacin, an old drug with a new twist

  2013cited by this paper
• Prostaglandins and Rheumatoid Arthritis

  2012cited by this paper
• Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms

  2012cited by this paper
• Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models.

  2012cited by this paper
• Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

  2011cited by this paper
• Ulcerative colitis.

  2011cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2011cited by this paper
• Genetics and pathogenesis of inflammatory bowel disease

  2011cited by this paper
• Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.

  2011cited by this paper
• Nicotinic Acid Has Anti-atherogenic and Anti-inflammatory Properties on Advanced Atherosclerotic Lesions Independent of its Lipid-modifying Capabilities

  2011cited by this paper
• Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice.

  2010cited by this paper
• A pro-resolution mediator, prostaglandin D2, is specifically up-regulated in individuals in long-term remission from ulcerative colitis

  2010cited by this paper
• Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

  2010cited by this paper
• Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.

  2010cited by this paper
• PG F2α Receptor: A Promising Therapeutic Target for Cardiovascular Disease

  2010cited by this paper
• Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.

  2009cited by this paper
• Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

  2009cited by this paper
• Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development

  2009cited by this paper
• Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.

  2009cited by this paper
• Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice

  2008cited by this paper
• Nicotinic acid: an old drug with a promising future

  2008cited by this paper
• Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.

  2008cited by this paper
• Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ12–14 PGJ2

  2007cited by this paper
• Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation.

  2007cited by this paper
• Anti-inflammatory effect is an important property of niacin on atherosclerosis beyond its lipid-altering effects.

  2007cited by this paper
• Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation.

  2007cited by this paper
• Chemically induced mouse models of intestinal inflammation

  2007influential reference
• Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue

  2007cited by this paper
• Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease.

  2006cited by this paper
• Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans Cells

  2006cited by this paper
• Prostaglandin D2 Plays an Essential Role in Chronic Allergic Inflammation of the Skin via CRTH2 Receptor1

  2006influential reference
• Langerhans cells release prostaglandin D2 in response to nicotinic acid.

  2006cited by this paper
• Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.

  2006cited by this paper
• Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients—A Pilot Uncontrolled Study

  2005cited by this paper
• The Spectrum of Gastrointestinal Toxicity and Effect on Disease Activity of Selective Cyclooxygenase-2 Inhibitors in Patients with Inflammatory Bowel Disease

  2004cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2004cited by this paper
• Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine

  2003cited by this paper
• Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid*

  2003cited by this paper
• Exacerbation of inflammatory bowel disease associated with use of celecoxib

  2001influential reference
• Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.

  2000cited by this paper
• Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

  2000cited by this paper
• Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

  2000influential reference
• Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice.

  1998cited by this paper
• ULCERATIVE colitis.

  1997cited by this paper
• Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

  1993cited by this paper
• The development of a method for the preparation of rat intestinal epithelial cell primary cultures.

  1992cited by this paper
• The Development of

  1965cited by this paper
• [Ulcerative colitis].

  1958cited by this paper
• the original work is properly cited.

  year unknowncited by this paper

• Segment-specific amelioration of gut homeostasis by vitamin B3 in high-fat diet-fed mice: Roles in barrier integrity, inflammatory response, and microbiota composition.

  2026cites this paper
• Prostaglandins and Inflammatory Bowel Disease: From Mechanism to Clinic.

  2025cites this paper
• Cimifugin ameliorates ulcerative colitis-related lung injury by modulating the JAK1/STAT1 signaling pathway and macrophage M1 polarization

  2025cites this paper
• HIV-associated gut dysbiosis drives oncogenesis through metabolic-immune crosstalk: mechanisms and therapeutic implications

  2025cites this paper
• Macrophage Metabolic Reprogramming in Inflammatory Bowel Diseases: From Pathogenesis to Therapy

  2025cites this paper
• Bidirectional Interplay Between IBD Therapies and the Gut Microbiota: A Pharmacomicrobiomic Approach to Personalized Treatment

  2025cites this paper
• Valorizing agro-food waste for microbial B vitamin biosynthesis: impacts on gut microbiota dynamics and microbial communication

  2025cites this paper
• Glomerular Haematopoietic Prostaglandin D Synthase‐Prostaglandin D2 Axis Contributes to the Periodontitis‐Related Exacerbation of Diabetic Nephropathy in KK‐Ay Mice

  2025cites this paper
• Artemisia herba alba: HPLC analysis, ADMET predictions, and anti-inflammatory Activity in chronic colitis model

  2025cites this paper
• Evaluating the link between the dietary intake of vitamin B and constipation: a population-based study

  2025cites this paper
• Dual roles of the TLR2/TLR4/NLRP3-H-PGDS-PGD2 axis in regulating the inflammatory response in Escherichia coli-infected bovine bone marrow-derived macrophages and endometrial tissue.

  2025cites this paper
• Microbiota-derived metabolites in inflammatory bowel disease

  2025cites this paper
• Vitamin Bs as Potent Anticancer Agents through MMP-2/9 Regulation.

  2025cites this paper
• A pro-inflammatory diet is associated with growth and virulence of Escherichia coli in pediatric Crohn's disease.

  2025cites this paper
• Butyrate, Valerate, and Niacin Ameliorate Anaphylaxis by Suppressing IgE-Dependent Mast Cell Activation: Roles of GPR109A, PGE2, and Epigenetic Regulation.

  2024cites this paper
• Exploring the promising potential of alcohol extract from the aerial part of dill in ameliorating DSS-induced ulcerative colitis in mice.

  2024cites this paper
• Candida tropicalis-derived vitamin B3 exerts protective effects against intestinal inflammation by promoting IL-17A/IL-22-dependent epithelial barrier function

  2024cites this paper
• Identification of distinct stool metabolites in women with endometriosis for non-invasive diagnosis and potential for microbiota-based therapies.

  2024cites this paper
• A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction

  2024cites this paper
• Helix pomatia mucin alleviates DSS-induced colitis in mice: Unraveling the cross talk between microbiota and intestinal chemokine

  2024cites this paper
• PGD2/DP1 axis promotes liver regeneration by secreting Wnt2 in Kupffer cells in mice.

  2024cites this paper
• Roles of prostaglandins in immunosuppression.

  2024cites this paper
• Microbiome Dysbiosis, Dietary Intake and Lifestyle-Associated Factors Involve in Epigenetic Modulations in Colorectal Cancer: A Narrative Review

  2024cites this paper
• Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease

  2024cites this paper
• Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases.

  2024cites this paper
• Evaluating the Release of Different Commercial Orally Modified Niacin Formulations In Vitro

  2023influential citation
• B Vitamins, Glucoronolactone and the Immune System: Bioavailability, Doses and Efficiency

  2023cites this paper
• Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage

  2023cites this paper
• Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

  2023cites this paper
• Nourishing Yin and moistening dryness formula inhibits colon cell apoptosis via activating the PI3K/AKT signaling pathway to ameliorate Yin-deficiency constipation in mice

  2023cites this paper
• Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment

  2023cites this paper
• Role of micronutrients in inflammatory bowel disease

  2023cites this paper
• Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms.

  2023cites this paper
• NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota

  2023cites this paper
• The Relevance of Food Constituents to the Irritable Bowel Syndrome: A Rome IV-Based Prevalence Study Among Medical Students

  2023cites this paper
• Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.

  2023cites this paper
• Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

  2023cites this paper
• Crosstalk between omega-6 oxylipins and the enteric nervous system: Implications for gut disorders?

  2023cites this paper
• Effects of ileocolonic delivered vitamin B2, B3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn’s disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial

  2023cites this paper
• Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease

  2023cites this paper
• Identifying metabolic shifts in Crohn's disease using 'omics-driven contextualized computational metabolic network models

  2023cites this paper
• Spraying compound probiotics improves growth performance and immunity and modulates gut microbiota and blood metabolites of suckling piglets

  2022cites this paper
• Elucidation of the Reinforcing Spleen Effect of Jujube Fruits Based on Metabolomics and Intestinal Flora Analysis

  2022cites this paper
• B Vitamins and Their Roles in Gut Health

  2022cites this paper
• A Novel Probiotic Bacillus subtilis Strain Confers Cytoprotection to Host Pig Intestinal Epithelial Cells during Enterotoxic Escherichia coli Infection

  2022cites this paper
• Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease

  2022cites this paper
• Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction

  2022cites this paper
• Unveiling of dietary and gut-microbiota derived B vitamins: Metabolism patterns and their synergistic functions in gut-brain homeostasis

  2022cites this paper
• Effect of Different Levels of Niacin on Serum Biochemical Parameters, Antioxidant Status, Cytokine Levels, Inflammatory Gene Expression and Colonic Microbial Composition in Weaned Piglets

  2022cites this paper
• Effects of niacin on intestinal immunity, microbial community and intestinal barrier in weaned piglets during starvation.

  2021cites this paper
• The roles of microbial products in the development of colorectal cancer: a review

  2021cites this paper
• Nutritional deficiency recapitulates intestinal injury associated with environmental enteric dysfunction in patient-derived Organ Chips

  2021cites this paper
• Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease

  2021cites this paper
• Gut Microbiome and Gastrointestinal Disorders

  2021cites this paper
• Harness the functions of gut microbiome in tumorigenesis for cancer treatment

  2021cites this paper
• PRKAR2A deficiency protects mice from experimental colitis by increasing IFN-stimulated gene expression and modulating the intestinal microbiota

  2021cites this paper
• Nicotinic Acid Upregulates Intestinal Antimicrobial Peptides via Manipulating the Histone Acetylation Modification to Enhance the Resistance of Escherichia Coli Infection in Weaned Piglets

  2021cites this paper
• Bacillus Subtilis 29784 as a Feed Additive for Broilers Shifts the Intestinal Microbial Composition and Supports the Production of Hypoxanthine and Nicotinic Acid

  2021cites this paper
• PGI2 Inhibits Intestinal Epithelial Permeability and Apoptosis to Alleviate Colitis

  2021cites this paper
• The microbiome and inflammatory bowel disease.

  2020cites this paper
• Prostaglandin E2 accelerated recovery of chemotherapy-induced intestinal damage by increasing expression of cyclin D.

  2020cites this paper
• DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells

  2020cites this paper
• Identifying metabolomic profiles of inflammatory diets in postmenopausal women.

  2020cites this paper
• Study of metabolic alterations in inflammatory bowel diseases

  2020cites this paper
• Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages

  2020cites this paper
• Modulatory Effect of Nicotinic Acid on the Metabolism of Caco-2 Cells Exposed to IL-1β and LPS

  2020cites this paper
• Protection against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Neferine, A Natural Product from Nelumbo nucifera Gaertn

  2020cites this paper
• SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells

  2020cites this paper
• Dietary cellulose prevents gut inflammation by modulating lipid metabolism and gut microbiota

  2020cites this paper
• Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

  2020cites this paper
• Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

  2019cites this paper
• 1 Eicosanoids in tissue repair

  2019cites this paper
• Current perspectives Themicrobiome and inflammatory bowel disease

  2019cites this paper
• Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A

  2019cites this paper
• Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD

  2019cites this paper
• Identifying Metabolomic Profiles of Insulinemic Dietary Patterns

  2019cites this paper
• Eicosanoids in tissue repair

  2019cites this paper
• The endogenous bioactive lipid prostaglandin D2‐glycerol ester reduces murine colitis via DP1 and PPARγ receptors

  2018cites this paper
• EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc

  2018cites this paper
• Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis

  2018cites this paper
• Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer

  2018cites this paper
• Panax notoginseng Promotes Repair of Colonic Microvascular Injury in Sprague-Dawley Rats with Experimental Colitis

  2018cites this paper
• Niacin ameliorates ulcerative colitis via prostaglandin D2‐mediated D prostanoid receptor 1 activation

  2017cites this paper